Ozempic, Wegovy, other anti-obesity drugs to flood biopharma industry in next 12 months; here’s what’s happening

Recent advancements in anti-obesity drugs have transformed the market, making them the most impactful trend for the next 12 months. Several anti-obesity drugs expected to come to the market in the next few years, including Ozempic (semaglutide), Mounjaro, Wegovy, and GL0034 (uretoglutide). Read The Rest at :